INO

INO

USD

Inovio Pharmaceuticals Inc. Common Stock

$2.430+0.000 (0.000%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.430

Haut

$2.575

Bas

$2.410

Volume

1.91M

Fondamentaux de l'Entreprise

Capitalisation Boursière

129.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.60M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.3Actuel $2.430Haut $5.8

Actualités Connexes

PR Newswire

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Voir plus
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
PR Newswire

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Voir plus
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Voir plus
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Voir plus
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
PR Newswire

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Voir plus
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.